43，Mcclellan KJ,Goa KL.Tirofiban:a review of its use in acute coronary syndrome.Drugs，1998，56(6)：1067
54，Ikeda H,Koga Y,Kuwano K,et al.Cyclic flow variations in a conscious dog model ofcoronary artery stenosis and endothelial injury correlate with acut e ischemic heartdisease syndromes in humans.J Am Coll Cardiol，1993，21(4)：100 8
65，Anderson HV,Kirkeeide RL,Krishnaswami A,et al.Cyclic flow variations after coronaryangioplasty in humans:clinical and angiographic characteristics and elimination with 7e3monoclonal antiplatelet antibody.J Am Coll Cardiol，199 4，235)：1031
76，Demrow HS,Slane PR,Folts JD.Administration of wine and grape juice i nhibits in vivoplatelet activity and thrombosis in stenosed canine arteries.Cir culation，1995，91(4)：1182
87，Folts JD,Schafer AI,Loscalzo J,et al.A perpective on the potential p roplems withaspirin as an antithrombotic agents:a comparison of studies in an a nimal model withclinical trials.J Am Coll Cardiol，1999，33(2)：295
4The Expert Committee on the Diagnosis and Classification of Diabetes Mellitus.Report of the expert committee on the diagnosis and classification of diabetes mellitus.Diabetes Care,1997,20:1 183～1 197.
5Ruf A,Patscheke H.Flow cytometric detection of activated platelets:Comparison of determining shape change,fibrinogen binding,and P-selection expression.Semin Thromb Hemost,1995,21:146～157.
